SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 29.67-2.5%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lee M. Davidson who wrote ()5/14/1996 9:10:00 PM
From: RICHARD LOCKIE   of 455
 
TO: LEE DAVIDSON
FROM: RICHARD LOCKIE

PROCEPT, INC IS ENGAGED IN THE RESEARCH AND DEVELOPMENT OF
MOLECULE THERAPEUTIC PRODUCTS FOR TREATMENT OF IMMUNE SYSTEM
DISORDERS. REVENUES FELL 30% FOR THE NINE MONTHS ENDING
9/30/95. NET LOSS WAS $8.4 MILLION. LOSS WAS DUE TO LOWER
REVENUES RECEIVED FROM BRISTOL-MYERS SQUIBB. THEIR PHONE
NUMBER IS (617)-491-1100. THEIR FLOAT IS 5.7 MILLION AS OF
5/10/96. THE STOCK HAD A HIGH OF 7.75. LARGE VOLUMN SPIKES
OCCURRED IN DEC, FEB AND MAY, SUGGESTING SOME ACCUMULATION.

RICHARD LOCKIE
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News